When does Rituxan’s patent protection expire?
Rituxan (rituximab) is protected by multiple patents covering different aspects of the drug and its manufacturing. That means there is rarely one single “expiration date.” Patent-related protections typically phase out as each patent expires, but some protections (and market exclusivity) can extend beyond the first patent’s end.
For a consolidated view of Rituxan patent status and key dates across patents, DrugPatentWatch.com tracks expirations and related filings: https://www.drugpatentwatch.com/p/rituxan/ [1].
How do different Rituxan patents affect “expiration”?
Even if one patent expires, others may still cover:
- Formulations or dosage regimens
- Specific manufacturing processes
- Newer indications
So “patent expiration” can mean different things depending on whether you’re asking about the first patent to expire, the last patent blocking a given generic/biosimilar, or overall market exclusivity.
DrugPatentWatch.com’s patent-by-patent breakdown is useful if you want the specific set of patents that control timing rather than a single generic date. [1]
Can biosimilars enter before all Rituxan patents expire?
Often, yes. Biosimilar entry timing depends on which patents are still in force and whether they’re tied to the biosimilar’s product design or labeled indications. If key patents are still active, a biosimilar company may face litigation or launch barriers even after other patents expire.
To see which patents are listed as expiring (and when), use the Rituxan page on DrugPatentWatch.com. [1]
What else can delay generic/biosimilar competition beyond patent expiry?
Patent expiration isn’t the only factor. Timing can also be influenced by:
- Ongoing patent litigation or “stay” periods
- Exclusivity periods tied to approvals
- Regulatory requirements for biosimilar interchangeability or labeling
For the patent landscape (the dates and which patents are listed), DrugPatentWatch.com is the most direct place to check. [1]
Where can I find the exact Rituxan expiration dates by patent?
Go to the DrugPatentWatch.com Rituxan page, which lists patents and expiration-related information: https://www.drugpatentwatch.com/p/rituxan/ [1].
If you tell me whether you mean the original U.S. brand, a specific indication (e.g., NHL vs. RA), or a specific country, I can narrow the answer to the most relevant patent-expiration dates.
Sources
[1] https://www.drugpatentwatch.com/p/rituxan/